Table 3.
Simulated average drug responses (expressed as percentages of the maximum possible average drug response, i.e., the response obtained with 10 mg kg−1 meloxicam) for different end points and doses ranging from 0.1 to 1 mg kg−1
Average response (from 0 to 100%) | Meloxicam dose (mg kg−1) | ||||||||
---|---|---|---|---|---|---|---|---|---|
End point | E0.1a | E0.2a | E0.3a | E0.4a | E0.5a | E1a | ED50b | ED70b | ED90b |
Skin temperature difference | 0.05 | 3.60 | 23.9 | 49.8 | 70.6 | 98.4 | 0.40 | 0.50 | 0.67 |
Pain score | 0.02 | 11.30 | 51.2 | 81.1 | 94.9 | 99.4 | 0.30 | 0.36 | 0.45 |
Body temperature | 1.6 | 34.90 | 72.4 | 90.7 | 96.5 | 99.5 | 0.235 | 0.29 | 0.39 |
Lameness score | 0.2 | 21.9 | 63.7 | 87.2 | 95.9 | 99.3 | 0.26 | 0.32 | 0.42 |
Overall locomotion variable | 0.03 | 15.80 | 59.4 | 86.1 | 96.2 | 99.3 | 0.275 | 0.33 | 0.43 |
EX (%) represents the predicted average drug response for a single s.c. dose of X mg kg−1 meloxicam.
EDY (mg kg−1) is the meloxicam dose producing Y% of the maximum possible average drug response that can be obtained with a single s.c. administration of meloxicam.